Enasidenib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Enasidenib is used to treat acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation in patients who have not responded to other treatments or to those whose cancer has come back after treatment.Enasidenib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Enasidenib Nitroso Impurity 2 CAS NO: NA chemically represented as N-(4-((2-Hydroxy-2-methylpropyl)(nitroso)amino)-6-(6-(trifluoromethyl)pyridin-2-yl)-1,3,5-triazin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)nitrous amide. Synchemia is the leading manufacturing and exporter of Enasidenib Nitroso Impurity 2 . We supply Enasidenib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142916 |
| CAS No | NA |
| Mol.F. | C21H21N5O4 |
| Mol.Wt. | 407.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142917 |
| CAS No | NA |
| Mol.F. | C23H27ClN4O6S |
| Mol.Wt. | 523.0 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142918 |
| CAS No | NA |
| Mol.F. | C16H16ClN3O5S |
| Mol.Wt. | 397.83 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142919 |
| CAS No | NA |
| Mol.F. | C18H18ClN3O7S |
| Mol.Wt. | 455.87 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142920 |
| CAS No | NA |
| Mol.F. | C22H33N5O5S |
| Mol.Wt. | 479.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142921 |
| CAS No | NA |
| Mol.F. | C21H25ClN4O6S |
| Mol.Wt. | 496.96 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142922 |
| CAS No | NA |
| Mol.F. | C23H26Cl2N4O6S |
| Mol.Wt. | 557.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142923 |
| CAS No | NA |
| Mol.F. | C16H16ClN3O5S |
| Mol.Wt. | 397.83 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142924 |
| CAS No | NA |
| Mol.F. | C16H16ClN3O5S |
| Mol.Wt. | 397.83 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142925 |
| CAS No | NA |
| Mol.F. | C24H33N5O6S |
| Mol.Wt. | 519.62 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142926 |
| CAS No | NA |
| Mol.F. | C24H33N5O6S |
| Mol.Wt. | 519.62 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142927 |
| CAS No | NA |
| Mol.F. | C18H22N4O7S |
| Mol.Wt. | 438.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142928 |
| CAS No | NA |
| Mol.F. | C16H20N4O5S |
| Mol.Wt. | 380.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142929 |
| CAS No | NA |
| Mol.F. | C24H33N5O6S |
| Mol.Wt. | 519.62 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142930 |
| CAS No | NA |
| Mol.F. | C18H22N4O7S |
| Mol.Wt. | 438.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142931 |
| CAS No | NA |
| Mol.F. | C19H24N4O7S |
| Mol.Wt. | 452.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |